NEW PUBLICATIONS UPTO AUG. 31ST 2015 ON DRY EYE DIAGNOSIS AND THERAPEUTICS Glaucoma and Dry Eye: A Tough Combo How chronic glaucoma treatment can give rise to ocular surface disease, and how you can treat them both. Mark B. Abelson, MD, CM, FRCSC, FARVO,...

AMAKEM THERAPEUTICS Amakem is a clinical stage ophthalmology company developing innovative new treatments for serious eye conditions. The Company’s lead program is based on AMA0076, a novel, locally-acting Rho kinase (ROCK) inhibitor, in clinical development...

Envisioning New Therapies Register Today | View Preliminary Agenda Ophthalmological pharmacology has historically lacked systematic understanding of disease mechanisms, especially of those for the back of the eye. This is now changing with the discovery...